keyword
https://read.qxmd.com/read/38599976/anti-cd20-monoclonal-antibodies-in-multiple-sclerosis-rethinking-the-current-treatment-strategy
#21
REVIEW
S A Freeman, H Zéphir
Anti-CD20 monoclonal antibodies are highly-effective B-cell-depleting therapies in multiple sclerosis (MS). These treatments have expanded the arsenal of highly effective disease-modifying therapies, and have changed the landscape in understanding the pathophysiology of MS and the natural course of the disease. Nevertheless, these treatments come at the cost of immunosuppression and risk of serious infections, diminished vaccination response and treatment-related secondary hypogammaglobulinemia. However, the COVID pandemic has given way to a possibility of readapting these therapies, with most notably extended dosing intervals...
April 9, 2024: Revue Neurologique
https://read.qxmd.com/read/38594058/combined-inhibition-of-il-1-il-33-and-il-36-signalling-by-targeting-il1rap-ameliorates-skin-and-lung-fibrosis-in-preclinical-models-of-systemic-sclerosis
#22
JOURNAL ARTICLE
Caitríona Grönberg, Sara Rattik, Cuong Tran-Manh, Xiang Zhou, Aleix Rius Rigau, Yi-Nan Li, Andrea-Hermina Györfi, Nicholas Dickel, Meik Kunz, Alexander Kreuter, Emil-Alexandru Matei, Honglin Zhu, Petter Skoog, David Liberg, Jörg Hw Distler, Thuong Trinh-Minh
BACKGROUND: The interleukin (IL)-1 receptor accessory protein (IL1RAP) is an essential coreceptor required for signalling through the IL-1, IL-33 and IL-36 receptors. Here, we investigate the antifibrotic potential of the combined inhibition of these cytokines by an anti-IL1RAP antibody to provide a scientific background for clinical development in systemic sclerosis (SSc). METHODS: The expression of IL1RAP-associated signalling molecules was determined by data mining of publicly available RNA sequencing (RNAseq) data as well as by imaging mass cytometry...
April 9, 2024: Annals of the Rheumatic Diseases
https://read.qxmd.com/read/38591917/tetracyclic-homoisoflavanoid-brazilin-a-natural-product-inhibits-c-di-amp-producing-enzyme-and-streptococcus-mutans-biofilms
#23
JOURNAL ARTICLE
Edwin M Rojas, Hua Zhang, Sadanandan E Velu, Hui Wu
The tenacious biofilms formed by Streptococcus mutans are resistant to conventional antibiotics and current treatments. There is a growing need for novel therapeutics that selectively inhibit S. mutans biofilms while preserving the normal oral microenvironment. Previous studies have shown that increased levels of cyclic di-AMP, an important secondary messenger synthesized by diadenylate cyclase (DAC), favored biofilm formation in S. mutans . Thus, targeting S. mutans DAC is a novel strategy to inhibit S. mutans biofilms...
April 9, 2024: Microbiology Spectrum
https://read.qxmd.com/read/38586631/the-frequency-of-intraocular-pressure-elevation-incidence-of-secondary-glaucoma-and-surgical-treatment-with-postoperative-complications-in-pediatric-and-adult-patients-with-uveitis
#24
JOURNAL ARTICLE
Cem Evereklioglu, Tülay Karacan Erşekerci, Hatice Kübra Sönmez, Hidayet Sener, Duygu Gulmez Sevim, Osman Ahmet Polat, Hatice Arda, Fatih Horozoglu
Purpose To determine the etiology and anatomic localization of uveitis, the frequency of intraocular pressure (IOP) elevation, and the type of secondary glaucoma and to assess the medical, surgical, and postoperative complications in adult and pediatric patients with acute or chronic uveitis. Methods A total of 307 eyes of 186 patients who were followed up in the Uvea-Behçet Unit of the Ophthalmology Department, Erciyes University, Turkey, were included in the study. Demographic, ocular, and systemic data were recorded; ophthalmological examinations were performed; and recurrences and complications of uveitis were identified...
March 2024: Curēus
https://read.qxmd.com/read/38583821/inhalable-fn-binding-liposomes-or-liposome-exosome-hybrid-bionic-vesicles-encapsulated-microparticles-for-enhanced-pulmonary-fibrosis-therapy
#25
JOURNAL ARTICLE
Xiuhua Wang, Wei Wan, Jing Lu, Peiqing Liu
Pulmonary fibrosis (PF) is a chronic, progressive and irreversible interstitial lung disease that seriously threatens human life and health. Our previous study demonstrated the unique superiority of traditional Chinese medicine cryptotanshinone (CTS) combined with sustained pulmonary drug delivery for treating PF. In this study, we aimed to enhance the selectivity, targeting efficiency and sustained-release capability based on this delivery system. To this end, we developed and evaluated CTS-loaded modified liposomes-chitosan (CS) microspheres SM(CT-lipo) and liposome-exosome hybrid bionic vesicles-CS microspheres SM(LE)...
April 5, 2024: International Journal of Pharmaceutics
https://read.qxmd.com/read/38583489/acute-respiratory-failure-caused-by-brainstem-demyelinating-lesions-in-an-older-patient-with-an-atypical-relapsing-autoimmune-disorder
#26
Shoko Hongo, Hiroshi Shimizu, Etsuji Saji, Akihiro Nakajima, Kouichirou Okamoto, Izumi Kawachi, Osamu Onodera, Akiyoshi Kakita
An 84-year-old man presented with somnolence, dysphagia, and right hemiplegia, all occurring within a month, approximately one year after initial admission due to subacute, transient cognitive decline suggestive of acute disseminated encephalomyelitis involving the cerebral white matter. Serial magnetic resonance imaging (MRI) studies over that period revealed three high-intensity signal lesions on fluid-attenuated inversion recovery images, appearing in chronological order in the left upper and left lower medulla oblongata and left pontine base...
April 7, 2024: Neuropathology: Official Journal of the Japanese Society of Neuropathology
https://read.qxmd.com/read/38581051/development-of-a-multiplex-droplet-digital-pcr-method-for-detection-and-monitoring-of-mycobacterium-tuberculosis-and-drug-resistant-tuberculosis
#27
JOURNAL ARTICLE
Yu Jeong Choi, Yoonjung Kim, Hye Jung Park, Dokyun Kim, Hyukmin Lee, Young Ah Kim, Kyung-A Lee
BACKGROUND: The prevalence of multidrug-resistant tuberculosis (MDR-TB) among Korean tuberculosis patients is about 4.1%, which is higher than the OECD average of 2.6%. Inadequate drug use and poor patient compliance increase MDR-TB prevalence through selective pressure. Therefore, prompt detection of drug resistance in tuberculosis patients at the time of diagnosis and quantitative monitoring of these resistant strains during treatment are crucial. METHODS: A multiplex droplet digital PCR (ddPCR) assay was developed and assessed using DNA material of nine Mycobacterium tuberculosis strains with known mutation status that were purchased from the Korean National Tuberculosis Association...
April 5, 2024: Annals of Clinical Microbiology and Antimicrobials
https://read.qxmd.com/read/38579568/fcgr3a-v158f-gene-polymorphism-a-potential-predictor-for-rituximab-dosing-optimization-in-chinese-patients-with-neuromyelitis-optica-spectrum-disorder
#28
JOURNAL ARTICLE
Lei Cui, Jinsong Jiao, Yeqiong Zhang, Renbin Wang, Dantao Peng, Yujuan Jiao, Weihe Zhang
BACKGROUND: Rituximab (RTX), an anti-CD20 monoclonal antibody, has shown promise in managing neuromyelitis optica spectrum disorders (NMOSD) by depleting B cells and reducing relapses. However, there is no consensus on the optimal RTX dosing regimen, and genetic factors, such as FCGR3A-V158F polymorphism, may influence treatment outcomes. This study investigates how FCGR3A-V158F genotypes influence RTX efficacy in Chinese NMOSD patients under varying dosing regimens and aims to optimize treatment protocols...
April 1, 2024: Multiple Sclerosis and related Disorders
https://read.qxmd.com/read/38578494/risk-of-hepatitis-b-virus-reactivation-in-people-with-multiple-sclerosis-treated-with-ocrelizumab-an-observational-study-from-turkey
#29
JOURNAL ARTICLE
Muammer Çelik, Cavid Baba, Çağlar Irmak, Serkan Özakbaş, Vildan Avkan-Oğuz
BACKGROUND: The risk of hepatitis B virus (HBV) reactivation remains unclear in people with multiple sclerosis (MS) receiving ocrelizumab. We aimed to assess HBV seroprevalence and reactivation risk in MS patients on ocrelizumab and to evaluate the effectiveness of antiviral prophylaxis against HBV reactivation. METHODS: In this single-center, cross-sectional study, 400 people with MS receiving ocrelizumab were screened for HBV at baseline and antiviral prophylaxis was implemented based on serological results...
April 5, 2024: Journal of Neurology
https://read.qxmd.com/read/38578274/antibody-mediated-depletion-of-autoreactive-t-lymphocytes-through-pd-1-improves-disease-outcomes-and-visualizes-t-cell-activation-in-experimental-autoimmune-encephalomyelitis
#30
JOURNAL ARTICLE
Connor Frank, Hannah E Salapa, Kevin J H Allen, Michael C Levin, Wojciech Dawicki, Ekaterina Dadachova
Long-term therapeutic outcomes of multiple sclerosis (MS) remain hindered by the chronic nature of immune cell stimulation toward self-antigens. Development of novel methods to target and deplete autoreactive T lymphocytes remains an attractive target for therapeutics for MS. We developed a programmed cell death 1 (PD-1)-targeted radiolabeled mAb and assessed its ability to deplete activated PD-1+ T lymphocytes in vitro and its ability to reduce disease burden of the myelin oligodendrocyte glycoprotein 35-55 experimental autoimmune encephalomyelitis (EAE) model in C57BL/6 mice...
April 5, 2024: Journal of Immunology
https://read.qxmd.com/read/38577249/high-rate-of-progression-to-symptomatic-multiple-myeloma-in-patients-with-smoldering-myeloma-and-isolated-osteoporotic-vertebral-fracture
#31
JOURNAL ARTICLE
Kevin Chevalier, Sabrina Hamroun, Samuel Bitoun, Julien Henry, Christian Roux, Karine Briot, Rakiba Belkhir, Xavier Mariette, Raphaèle Seror
Multiple myeloma (MM) frequently causes vertebral fractures (VF). Some are lytic lesions and others have the aspect of benign osteoporotic fractures not requiring anti-myeloma treatment. We explored outcome of these patients with smoldering myeloma (SM) and osteoporotic VF. In this retrospective bi-centric study, patients were identified using a systematic keyword search on electronic medical records. Patients with SM and isolated VF of osteoporotic aspect without indications for myeloma-specific therapy were included...
June 2024: Bone Reports
https://read.qxmd.com/read/38576928/guillain-barre-syndrome-following-covid-19-vaccination-a-study-of-70-case-reports
#32
REVIEW
Biki Kumar Sah, Zahra Fatima, Rajan Kumar Sah, Bushra Syed, Tulika Garg, Selia Chowdhury, Bikona Ghosh, Binita Kunwar, Anagha Shree, Vivek Kumar Sah, Anisha Raut
BACKGROUND AND OBJECTIVE: Guillain-Barre syndrome (GBS) has been found to have some interesting association with vaccinations. This paper mainly focuses on exploring different associations between COVID-19 vaccination and GBS. METHODS: Electronic databases such as PubMed, Google Scholar, Cochrane, and Embase were searched using MESH terms for case reports published till 1 August 2023 from which 70 case reports were documented involving 103 individuals from 23 different countries...
April 2024: Annals of Medicine and Surgery
https://read.qxmd.com/read/38572731/prevention-of-colon-enlargement-by-tnf-%C3%AE-antagonist-in-a-streptozotocin-induced-diabetic-rat-model
#33
JOURNAL ARTICLE
Tri Agusti Sholikah, Dian Eurike Septyaningtrias, Yustina Andwi Ari Sumiwi, Muthmainah Muthmainah, Rina Susilowati
PURPOSE: We investigated the effect of tumor necrosis factor (TNF)-α antagonist on the structure and function of the streptozotocin-nicotinamide (STZ-NA)-induced diabetic rat colon. METHODS: Thirty rats were divided into normal control (NC), diabetic control (DC), and diabetic etanercept (DE) groups. The DE group was injected with etanercept twice a week. Blood glucose, body weight, fecal pellet, colonic transit time, and plasma TNF-α were measured. The colon was dissected out, followed by weight and length measurements...
March 18, 2024: Histology and Histopathology
https://read.qxmd.com/read/38570068/pharmacological-blockade-of-2-ag-degradation-ameliorates-clinical-neuroinflammatory-and-synaptic-alterations-in-experimental-autoimmune-encephalomyelitis
#34
JOURNAL ARTICLE
Livia Guadalupi, Georgia Mandolesi, Valentina Vanni, Sara Balletta, Silvia Caioli, Anto Pavlovic, Francesca De Vito, Diego Fresegna, Krizia Sanna, Laura Vitiello, Monica Nencini, Alice Tartacca, Fabrizio Mariani, Valentina Rovella, Sven Schippling, Iris Ruf, Ludovic Collin, Diego Centonze, Alessandra Musella
The endocannabinoid system (ECS) is critically involved in the pathophysiology of Multiple Sclerosis (MS), a neuroinflammatory and neurodegenerative disease of the central nervous system (CNS). Over the past decade, researchers have extensively studied the neuroprotective and anti-inflammatory effects of the ECS. Inhibiting the degradation of the endocannabinoid 2-arachidonoylglycerol (2-AG) has emerged as a promising strategy to mitigate brain damage in MS. In this study, we investigated the effects of a novel reversible MAGL inhibitor (MAGLi 432) on C57/BL6 female mice with experimental autoimmune encephalomyelitis (EAE), a model of MS...
April 1, 2024: Neuropharmacology
https://read.qxmd.com/read/38566992/an-updated-advancement-of-bifunctional-il-27-in-inflammatory-autoimmune-diseases
#35
REVIEW
Wang-Dong Xu, Da-Cheng Wang, Ming Zhao, An-Fang Huang
Interleukin-27 (IL-27) is a member of the IL-12 family. The gene encoding IL-27 is located at chromosome 16p11. IL-27 is considered as a heterodimeric cytokine, which consists of Epstein-Barr virus (EBV)-induced gene 3 (Ebi3) and IL-27p28. Based on the function of IL-27, it binds to receptor IL-27rα or gp130 and then regulates downstream cascade. To date, findings show that the expression of IL-27 is abnormal in different inflammatory autoimmune diseases (including systemic lupus erythematosus, rheumatoid arthritis, Sjogren syndrome, Behcet's disease, inflammatory bowel disease, multiple sclerosis, systemic sclerosis, type 1 diabetes, Vogt-Koyanagi-Harada, and ankylosing spondylitis)...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38566910/exploring-the-association-between-weight-loss-inducing-medications-and-multiple-sclerosis-insights-from-the-fda-adverse-event-reporting-system-database
#36
JOURNAL ARTICLE
Afsaneh Shirani, Anne H Cross, Olaf Stuve
BACKGROUND: Several studies have demonstrated that early childhood and adolescent obesity are risk factors for multiple sclerosis (MS) susceptibility. Obesity is thought to share inflammatory components with MS through overproduction of pro-inflammatory adipokines (e.g., leptin) and reduction of anti-inflammatory adipokines (e.g, adiponectin). Recently, drug repurposing (i.e. identifying new indications for existing drugs) has garnered significant attention. The US Food and Drug Administration Adverse Event Reporting System (FAERS) database serves not only as a resource for mining adverse drug reactions and safety signals but also for identifying inverse associations and potential medication repurposing opportunities...
2024: Therapeutic Advances in Neurological Disorders
https://read.qxmd.com/read/38566376/immunoregulatory-effects-of-the-active-form-of-vitamin-d-calcitriol-individually-and-in-combination-with-curcumin-on-peripheral-blood-mononuclear-cells-pbmcs-of-multiple-sclerosis-ms-patients
#37
JOURNAL ARTICLE
Mahdieh Fasihi, Mahsa Samimi-Badabi, Behrouz Robat-Jazi, Sama Bitarafan, Abdorreza Naser Moghadasi, Fatemeh Mansouri, Mir Saeed Yekaninejad, Maryam Izad, Ali Akbar Saboor-Yaraghi
OBJECTIVES: Multiple sclerosis (MS) is a chronic autoimmune inflammatory disease affecting the central nervous system. Immune cell subsets, notably T helper (Th) 17 and Th1, exert important roles in MS pathogenesis. Whereas, Treg cells modulate the disease process. Calcitriol, the active form of vitamin D, and curcumin, a bioactive compound derived from turmeric, play immunomodulatory effects relevant to autoimmune disorders, including MS. The objective of this study is to investigate the effects of calcitriol and Curcumin on Peripheral blood mononuclear cells (PBMCs) of individuals with MS...
April 1, 2024: Anti-inflammatory & Anti-allergy Agents in Medicinal Chemistry
https://read.qxmd.com/read/38564996/blood-sphingolipid-as-a-novel-biomarker-in-patients-with-neuromyelitis-optica-spectrum-disorder
#38
JOURNAL ARTICLE
Hyunjin Kim, Hwa Jung Kim, Jungmin So, Ji Yon Kim, Hee-Jae Jung, Seungmi Kim, Dayoung Seo, Hyun-Ji Kim, Ha Eun Song, Young-Min Lim, Hyun Ju Yoo, Eun-Jae Lee
BACKGROUND: Sphingolipids are signaling molecules and structural components of the axolemma and myelin sheath. Plasma sphingolipid levels may reflect disease status of neuromyelitis optica spectrum disorder (NMOSD). We aimed to examine plasma sphingolipids as disease severity biomarkers for NMOSD and compare their characteristics with those of serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP). METHODS: We measured plasma sphingolipids, sNfL, and sGFAP levels in NMOSD cases with anti-aquaporin-4-antibody...
March 20, 2024: Multiple Sclerosis and related Disorders
https://read.qxmd.com/read/38563150/exploring-the-immune-modulating-properties-of-boswellic-acid-in-experimental-autoimmune-encephalomyelitis
#39
JOURNAL ARTICLE
Alireza Shadab, Mohammad Abbasi-Kolli, Esmaeil Yazdanpanah, Seyed-Alireza Esmaeili, Rasoul Baharlou, Bahman Yousefi, Dariush Haghmorad
Multiple sclerosis (MS) is a condition where the central nervous system loses its myelin coating due to autoimmune inflammation. The experimental autoimmune encephalomyelitis (EAE) simulates some aspects of human MS. Boswellic acids are natural compounds derived from frankincense extract, known for their anti-inflammatory properties. The purpose of this research was to investigate therapeutic potential of boswellic acids. Mice were divided into three groups: low-dose (LD), high-dose (HD), and control groups (CTRL)...
April 2, 2024: APMIS: Acta Pathologica, Microbiologica, et Immunologica Scandinavica
https://read.qxmd.com/read/38562292/hub-overload-and-failure-as-a-final-common-pathway-in-neurological-brain-network-disorders
#40
REVIEW
Cornelis Jan Stam
Understanding the concept of network hubs and their role in brain disease is now rapidly becoming important for clinical neurology. Hub nodes in brain networks are areas highly connected to the rest of the brain, which handle a large part of all the network traffic. They also show high levels of neural activity and metabolism, which makes them vulnerable to many different types of pathology. The present review examines recent evidence for the prevalence and nature of hub involvement in a variety of neurological disorders, emphasizing common themes across different types of pathology...
2024: Network Neuroscience
keyword
keyword
63284
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.